Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Mark D. Myslinski | M | 67 |
CytoVas LLC
 CytoVas LLC Data Processing ServicesTechnology Services CytoVas LLC develops informatics platform that provides information on novel cellular markers of disease progression and individual treatment response to clinicians and drug developers. The firm's platforms include Cloud Cytomics and CytoVas Vascular Health Profile. Cloud Cytomics provides automated data collection, mining, and modeling solutions to clinical researchers. CytoVas Vascular Health Profile provides cytometric vascular health event detection test for clinical studies. The company was founded by Emile Mohler, III, Jonni Moore and Wade Rogers and is headquartered in Philadelphia, PA. | - |
| Michael D. Poisel | M | - |
CytoVas LLC
CytoVas LLC Data Processing ServicesTechnology Services CytoVas LLC develops informatics platform that provides information on novel cellular markers of disease progression and individual treatment response to clinicians and drug developers. The firm's platforms include Cloud Cytomics and CytoVas Vascular Health Profile. Cloud Cytomics provides automated data collection, mining, and modeling solutions to clinical researchers. CytoVas Vascular Health Profile provides cytometric vascular health event detection test for clinical studies. The company was founded by Emile Mohler, III, Jonni Moore and Wade Rogers and is headquartered in Philadelphia, PA. | - |
| Todd Riley Johnson | M | - |
CytoVas LLC
CytoVas LLC Data Processing ServicesTechnology Services CytoVas LLC develops informatics platform that provides information on novel cellular markers of disease progression and individual treatment response to clinicians and drug developers. The firm's platforms include Cloud Cytomics and CytoVas Vascular Health Profile. Cloud Cytomics provides automated data collection, mining, and modeling solutions to clinical researchers. CytoVas Vascular Health Profile provides cytometric vascular health event detection test for clinical studies. The company was founded by Emile Mohler, III, Jonni Moore and Wade Rogers and is headquartered in Philadelphia, PA. | 12 ans |
| Jonni Moore | M | - |
CytoVas LLC
CytoVas LLC Data Processing ServicesTechnology Services CytoVas LLC develops informatics platform that provides information on novel cellular markers of disease progression and individual treatment response to clinicians and drug developers. The firm's platforms include Cloud Cytomics and CytoVas Vascular Health Profile. Cloud Cytomics provides automated data collection, mining, and modeling solutions to clinical researchers. CytoVas Vascular Health Profile provides cytometric vascular health event detection test for clinical studies. The company was founded by Emile Mohler, III, Jonni Moore and Wade Rogers and is headquartered in Philadelphia, PA. | - |
| Emile Mohler | M | - |
CytoVas LLC
CytoVas LLC Data Processing ServicesTechnology Services CytoVas LLC develops informatics platform that provides information on novel cellular markers of disease progression and individual treatment response to clinicians and drug developers. The firm's platforms include Cloud Cytomics and CytoVas Vascular Health Profile. Cloud Cytomics provides automated data collection, mining, and modeling solutions to clinical researchers. CytoVas Vascular Health Profile provides cytometric vascular health event detection test for clinical studies. The company was founded by Emile Mohler, III, Jonni Moore and Wade Rogers and is headquartered in Philadelphia, PA. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Allan R. Moser | M | - |
Cira Discovery Sciences, Inc.
 Cira Discovery Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Cira Discovery Sciences, Inc. creates new advanced algorithmic methods for analyzing High Dimensional Biology. The increasing availability of high-quality data from '-omics' methodologies represents an opportunity to create value for Life Sciences enterprises. It applies these methods: in close collaboration with scientists in the pharmaceutical and biotechnology industries to facilitate the discovery of safe and potent new medicines and in the development of more accurate and sensitive diagnostic tests for disease and drug response. The company was incorporated in 2003, by happy chance on the 50th anniversary of the publication of Watson and Crick's famous paper on the double-helical structure of DNA. | 9 ans |
| Jaspreet Longia | F | - |
Cira Discovery Sciences, Inc.
Cira Discovery Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Cira Discovery Sciences, Inc. creates new advanced algorithmic methods for analyzing High Dimensional Biology. The increasing availability of high-quality data from '-omics' methodologies represents an opportunity to create value for Life Sciences enterprises. It applies these methods: in close collaboration with scientists in the pharmaceutical and biotechnology industries to facilitate the discovery of safe and potent new medicines and in the development of more accurate and sensitive diagnostic tests for disease and drug response. The company was incorporated in 2003, by happy chance on the 50th anniversary of the publication of Watson and Crick's famous paper on the double-helical structure of DNA. | - |
| Michael Pellini | M | 58 |
Cira Discovery Sciences, Inc.
Cira Discovery Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Cira Discovery Sciences, Inc. creates new advanced algorithmic methods for analyzing High Dimensional Biology. The increasing availability of high-quality data from '-omics' methodologies represents an opportunity to create value for Life Sciences enterprises. It applies these methods: in close collaboration with scientists in the pharmaceutical and biotechnology industries to facilitate the discovery of safe and potent new medicines and in the development of more accurate and sensitive diagnostic tests for disease and drug response. The company was incorporated in 2003, by happy chance on the 50th anniversary of the publication of Watson and Crick's famous paper on the double-helical structure of DNA. | - |
| Jarod Robinson | M | - |
Cira Discovery Sciences, Inc.
Cira Discovery Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Cira Discovery Sciences, Inc. creates new advanced algorithmic methods for analyzing High Dimensional Biology. The increasing availability of high-quality data from '-omics' methodologies represents an opportunity to create value for Life Sciences enterprises. It applies these methods: in close collaboration with scientists in the pharmaceutical and biotechnology industries to facilitate the discovery of safe and potent new medicines and in the development of more accurate and sensitive diagnostic tests for disease and drug response. The company was incorporated in 2003, by happy chance on the 50th anniversary of the publication of Watson and Crick's famous paper on the double-helical structure of DNA. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 9 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Wade T. Rogers
- Réseau Personnel
